New eye scans could reveal Glaucoma's secrets

NCT ID NCT05370287

Recruiting now Knowledge-focused Sponsor: Food and Drug Administration (FDA) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study uses special cameras to take detailed pictures of the back of the eye in healthy people and those with glaucoma. Researchers want to see how blood flow and nerve cells change in glaucoma. The goal is to better understand the disease, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to detect and monitor glaucoma progression using advanced eye imaging.
What could go wrong: This is an observational study, not a treatment trial. It is small (150 people) and early-stage, so results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, PRIMARY OPEN ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, PRIMARY OPEN ANGLE

Contacts and locations

Locations

Food and Drug Administration
RECRUITING

Silver Spring, Maryland, 20993, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.